跳至主要内容
临床试验/NCT05168449
NCT05168449已完成不适用

The Impact of Pharmacist - Led Mobile Application on Medication Adherence and Efficacy in Chronic Kidney Disease Patients

Cairo University1 个研究点 分布在 1 个国家目标入组 86 人开始时间: 2022年9月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
86
试验地点
1
主要终点
Change in medication adherence

研究概览

简要总结

The aim of the study is to assess the impact of pharmacist led mobile application on adherence and efficacy of medication in chronic kidney disease patients

详细描述

This is a prospective randomized two group pharmacist-led interventional study that will be conducted in a private nephrology clinic. The study will involve introduction of the mobile phone applications to chronic kidney disease patients to improve their adherence to the prescribed medications.

Recruited patients will be randomly divided in two groups; intervention group and control group, with baseline evaluation of outcomes to be measured.

Control group will be provided with usual care. Intervention group will be provided in addition to the usual care, with an access to the mobile application after a simple training for app usage. Both groups will be followed for a period of 3 months.

The study will include the development, validation and the testing for evaluating the specially designed mobile application.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Stages 2-5 of chronic kidney disease
  • Ownership of android smart phone compatible with the application
  • Poly-pharmacy

排除标准

  • On dialysis due to loss of kidney function
  • Pregnancy due to altered physiology

结局指标

主要结局

Change in medication adherence

时间窗: Change from baseline at 3 months

Using a medication adherence questionnaire.

次要结局

  • Change in estimated glomerular filtration rate/ creatinine clearance(Change from baseline at 3 months)
  • Change in systolic and diastolic blood pressure(Change from baseline at 3 months)
  • Change in mobile application usability and acceptability by patients(Change from baseline at 3 months)
  • Change in HbA1c(Change from baseline at 3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shaza Gamal Abdel Fattah Ali Mohamed

Teaching Assistant

Cairo University

研究点 (1)

Loading locations...

相似试验